獣医用内視鏡の米国市場：製品タイプ別、処置タイプ別、動物タイプ別、エンドユーザー別、地域別、機会、予測、2018年～2032年

米国の獣医用内視鏡市場は、予測期間2025-2032年にCAGR 5.01%を記録し、2024年の7,729万米ドルから2032年には1億1,428万米ドルに成長すると予測されています。医療専門家は、動物の身体構造や臓器を検査するための低侵襲処置を実行するための特別なツールとして獣医用内視鏡を利用しています。米国における獣医用内視鏡市場は安定した成長を維持しています。これは、人々が低侵襲処置に対する理解を深め、技術が進歩する一方、ペットの飼い主がヘルスケアにより多くのお金を費やすからです。この市場は、様々な動物種、特に犬や猫を含むコンパニオンアニマルの診断や手術、治療を行うサービスを提供しています。高精細画像は、柔軟な内視鏡や特殊な器具とともに、臨床結果を向上させています。

高度な獣医学技術がペットの個体数の増加に伴って採用され、動物の健康が注目されるようになったため、市場は拡大しています。拡大する市場は、消化器、呼吸器、整形外科疾患のために内視鏡治療を必要とする患者数の増加によって支えられています。戦略的提携、最新技術、より良い動物ヘルスケア提供に焦点を当てた政府プログラムにより、市場は上昇の方向性を維持すると思われます。

さらに、獣医用内視鏡市場をサポートするために、保険会社はより良い診断治療のためにペットの飼い主に保険を提供しています。例えば、Frobe Advisorのレポートによると、2025年1月、米国で保険に加入しているペットは536万匹で、その約80％が犬であるのに対し、猫は20％です。このような投資は、ペットが早期診断と迅速なサービスを受けるのに役立ちます。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 米国の獣医用内視鏡市場の展望、2018年～2032年

• 市場規模分析と予測
  • 金額別
• 市場シェア分析と予測
  • 製品タイプ別
    • カプセル内視鏡
    • フレキシブル内視鏡
    • リジッド内視鏡
    • ロボット支援内視鏡
  • 処置タイプ別
    • 胃十二指腸鏡検査
    • 大腸内視鏡検査
    • 気管支鏡検査
    • その他
  • 動物タイプ別
    • コンパニオンアニマル
    • 家畜
  • エンドユーザー別
    • 動物病院
    • 学術機関
    • その他
  • 地域別
    • 北東部
    • 中西部
    • 西部
    • 南部
  • 企業別市場シェア分析（上位5社・その他- 金額別、2024年）
• 2024年市場マップ分析
  • 製品タイプ
  • 処置タイプ別
  • 動物タイプ別
  • エンドユーザー別
  • 地域別

第6章 需要供給分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

• 市場促進要因
• 市場の課題

第12章 市場動向と発展

第13章 規制枠組みとイノベーション

第14章 ケーススタディ

第15章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• トップ5社のSWOT分析
• 市場トップ10社の主要企業の情勢
  • STERIS plc
  • Nordion Inc.
  • KARL STORZ Endoscopy-America, Inc.
  • Dr. Fritz Endoscopes GmbH
  • Biovision Veterinary Endoscopy, LLC
  • Eickemeyer GmbH &Co. KG
  • Olympus America Inc.
  • Hill-Rom Holdings, Inc.
  • Advanced Monitors Corporation
  • B. Braun Medical Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Veterinary Endoscopy Market, By Value, In USD Million, 2018-2032F
• Figure 2. United States Veterinary Endoscopy Market Share (%), By Product Type, 2018-2032F
• Figure 3. United States Veterinary Endoscopy Market Share (%), By Procedure Type, 2018-2032F
• Figure 4. United States Veterinary Endoscopy Market Share (%), By Animal Type, 2018-2032F
• Figure 5. United States Veterinary Endoscopy Market Share (%), By End-user, 2018-2032F
• Figure 6. United States Veterinary Endoscopy Market Share (%), By Region, 2018-2032F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 8. By Procedure Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 9. By Animal Type Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 10. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2024
• Figure 11. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

United States veterinary endoscopy market is projected to witness a CAGR of 5.01% during the forecast period 2025-2032, growing from USD 77.29 million in 2024 to USD 114.28 million in 2032. Medical professionals utilize veterinary endoscopes as special tools to perform minimally invasive procedures for examining animal body structures and organs. The veterinary endoscopy market in the United States maintains steady growth because people understand minimally invasive procedures better and technology advances, while pet owners spend more money on healthcare. The market delivers services to diagnose and perform surgery and treatments for different animal species, especially companion animals, including dogs and cats. High-definition imaging, together with flexible endoscopes and specialized instruments, has improved clinical outcomes.

The market grows because advanced veterinary technologies are adopted by expanding pet populations, and animal health receives increased attention. The expanding market receives support from the growing number of patients who need endoscopic treatment for their gastrointestinal, respiratory, and orthopedic conditions. The market will maintain its rising direction due to strategic alliances, recent technologies, and government programs that focus on better veterinary healthcare delivery.

Additionally, to support the veterinary endoscopy market, insurance companies are providing insurance to the pet owners for better diagnostic treatment. For instance, in January 2025, as per the Frobe Advisor report, 5.36 million insured pets in the U.S., about 80% of which are dogs, compared to 20% of cats. Such an investment helps pets get an early diagnosis and rapid service.

Rising Prevalence of Pet Ownership Boosts United States Veterinary Endoscopy Market Demand

The growing number of pet owners establishes a powerful demand for veterinary endoscopic treatment services. The increasing number of people who keep pets in modern homes has resulted in greater attention to advanced animal healthcare solutions. Veterinary professionals prefer endoscopy because it delivers exact medical solutions through procedures that minimize pain while reducing both surgical complications and recovery times compared to traditional surgeries. People now understand pet health better, so they dedicate funds to quality veterinary care, which includes both diagnostic tests and disease prevention programs. People spend more on veterinary treatment because consumer wealth increases while knowledge about animal health improves. Veterinary clinics and hospitals now allocate increased financial resources toward purchasing endoscopic devices that enhance their diagnostic and therapeutic outcomes. Advanced procedures, such as endoscopy, gained better access through the establishment of specialized veterinary facilities in metropolitan areas and expanded pet insurance coverage. The increasing number of pets treated as family members creates greater demand for advanced veterinary procedures, including endoscopy.

For instance, in March 2025, according to the American Pet Products Association (APPA) survey report, 94 million U.S. households now own at least one pet, up from 82 million in 2023. The rising population of pets has increased the veterinary endoscopy market.

Investment in Research and Development Support Market Expansion

The expansion of the United States veterinary endoscopy market receives significant support through research and development (R&D) investments. New minimally invasive endoscopic technologies emerge from R&D advancements that improve diagnostic precision alongside treatment possibilities for animals. Research institutions and companies receive increased funding for developing safer, effective and user-friendly devices, which leads to greater veterinary practitioner adoption. Research and development funding supports the development of custom-made instruments that serve different animal types and medical needs. The technological advancements in veterinary endoscopy expanded its operational range while also increasing market growth through customer acquisition and expanded service capabilities. Continuous R&D activities prove vital for driving innovation and enhancing clinical results, which further drives the market growth of veterinary endoscopy throughout the United States.

For instance, in May 2024, a National non-profit organization Pecto Love in partnership with Blue Buffalo announced USD 1 million additionally invest to support treatment for pets fighting cancer disease on the occasion of May Pet Cancer Campaign before this announcement they already invest USD 20 million for the treatment of cancer, pet cancer research, and raise awareness about early detection of pet cancer.

Companion Animal Dominates the United States Veterinary Endoscopy Market Share

The United States veterinary endoscopy market experiences growth because of rising specialization in veterinary medicine, which focuses on companion animal care. Multiple veterinarians choose advanced endoscopy training to provide this service to common practices instead of referring patients to specialists. Endoscopic diagnostics and foreign body removals experienced increased demand due to the rising number of pets with obesity, along with their related diseases such as diabetes and pancreatitis. For instance, in November 2024, during National Pet Diabetes Month, it was reported that nearly 1 in 300 adult dogs and 1 in 230 cats in the United States are diagnosed with diabetes. Endoscopic therapies are vital because some breeds, specifically bulldogs, suffer from brachycephalic airway obstruction. The introduction of endoscopy education at veterinary schools produces new healthcare providers who feel comfortable working with this technology. The quest for competitive advantage among clinics leads to equipment adoption because pet owners choose practices that offer advanced technological capabilities. The market introduction of affordable specialized small animal endoscopes, which differ from repurposed human devices, makes it easier for companion animal practices to adopt this technology.

Veterinary Hospital Holds Largest United States Market Share for Veterinary Endoscopy

Veterinary hospitals hold a dominant position in the veterinary endoscopy market in the United States, primarily because they typically provide access to an all-inclusive range of diagnostics and healthcare. By providing a means to access modern endoscopic technology, these veterinary hospitals provide veterinary medical services that allow for the minimally invasive diagnostic and treatment of conditions for animals. The hospitals with staff trained in endoscopy have become the preferred facility for performing complicated procedures. The hospitals maintain their market leadership through their integrated high-quality care approach, which leads to constant growth in veterinary endoscopy services.

At the same time, pet owners have spent more money on their pets to help veterinary hospitals grow, which has expanded the veterinary endoscopy market share. For instance, according to the American Pet Products Association, estimated pet spending in the U.S. will reach USD 147 billion in 2023, of which USD 32 billion will be for supplies, live animals, and OTC medication, and USD 38.3 billion for vet care, product sales, etc.

Impact of U.S. Tariffs on Global Veterinary Endoscopy Market

The veterinary endoscopy market experiences substantial market changes because U.S. tariffs increase the costs for medical devices that are imported. Transportation costs rise when tariffs increase, which drives up manufacturing expenses, so veterinary clinics and hospitals face higher costs when purchasing endoscopic equipment. Such changes in market conditions cause practitioners to postpone or restrict their use of modern technology, which decreases overall market expansion. Tariff policies disrupt supply chains, which result in product shortages along with delivery delays. The financial strain from U.S. tariffs reduces veterinary endoscopy innovation and market growth while promoting domestic production and alternative supply sources to counteract these impacts.

Key Players Landscape and Outlook

Continuous innovation characterized the competitive landscape of the United States veterinary endoscopy market. The key players are looking for strategic partnerships between veterinary institutions and research facilities that serve as essential market expansion tools and a technology validation platform. Operational agility manifests through the creation of expansive product offerings that serve companion animals and livestock populations. Leading market players extend their distribution networks and service centers to reach emerging markets where veterinary care awareness shows growth potential.

In May 2023, Olympus Corporation (Olympus America Inc.) announced the acquisition of London-based Odin Vision, a cloud-AI endoscopy company, to establish a series of Digital Excellence Centers (DECs) for cloud-based applications.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. United States Veterinary Endoscopy Market Outlook, 2018-2032F

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product Type
    • 5.2.1.1. Capsule Endoscopes
    • 5.2.1.2. Flexible Endoscopes
    • 5.2.1.3. Rigid Endoscopes
    • 5.2.1.4. Robot-assisted Endoscopes
  • 5.2.2. By Procedure Type
    • 5.2.2.1. Gastroduodenoscopy
    • 5.2.2.2. Colonoscopy
    • 5.2.2.3. Bronchoscopy
    • 5.2.2.4. Others
  • 5.2.3. By Animal Type
    • 5.2.3.1. Companion Animal
      • 5.2.3.1.1. Dogs
      • 5.2.3.1.2. Cats
      • 5.2.3.1.3. Equine
      • 5.2.3.1.4. Others
    • 5.2.3.2. Livestock Animal
      • 5.2.3.2.1. Cattle
      • 5.2.3.2.2. Sheep
      • 5.2.3.2.3. Goats
      • 5.2.3.2.4. Others
  • 5.2.4. By End-user
    • 5.2.4.1. Veterinary Hospitals
    • 5.2.4.2. Academic Institutes
    • 5.2.4.3. Others
  • 5.2.5. By Region
    • 5.2.5.1. Northeast
    • 5.2.5.2. Midwest
    • 5.2.5.3. West
    • 5.2.5.4. South
  • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 5.3. Market Map Analysis, 2024
  • 5.3.1. By Product Type
  • 5.3.2. By Procedure Type
  • 5.3.3. By Animal Type
  • 5.3.4. By End-user
  • 5.3.5. By Region

6. Demand Supply Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. STERIS plc
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Nordion Inc.
  • 15.3.3. KARL STORZ Endoscopy-America, Inc.
  • 15.3.4. Dr. Fritz Endoscopes GmbH
  • 15.3.5. Biovision Veterinary Endoscopy, LLC
  • 15.3.6. Eickemeyer GmbH & Co. KG
  • 15.3.7. Olympus America Inc.
  • 15.3.8. Hill-Rom Holdings, Inc.
  • 15.3.9. Advanced Monitors Corporation
  • 15.3.10. B. Braun Medical Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer